Base de données de recherche subventionnée canadienne sur la COVID-19

Royal Roads University

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 51 through 60 of 107 results (Download Results)

Show results per page

COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Strynadka, Natalie C | University of British Columbia | Operating Grant | $100,000

CIHR British Columbia 2021

Preventing Opioid Deaths due to COVID Related Increase in Smoking Illicit Substances (Preventing OD CRISIS)

Moe, Jessica | B.C. Centre for Disease Control | Operating Grant | $200,000

CIHR British Columbia 2020

COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein

Perrin, David M | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Supplement – Assessing the impact of the COVID‑19 pandemic on social and health outcomes among young people: A mixed-method comparative analysis in Canada and France

Knight, Rodney E | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Nacul, Luis | B.C. Women's Hospital | Operating Grant | $742,331

CIHR British Columbia 2021

Investigating Neuropsychological Consequences of COVID‑19 on Adults, and Examination of Associated Risk and Resilience Factors

Paterson, Theone | University of Victoria | Operating Grant | $199,121

CIHR British Columbia 2021

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Investigating access to and outcomes from supervised drug consumption services in British Columbia before and during the COVID‑19 pandemic

Kerr, Thomas H | British Columbia Centre on Substance Use | Operating Grant | $249,065

CIHR British Columbia 2021

COVID-19 Variant Supplement – Canadian Treatments for COVID-19: SOLIDARITY

Murthy, Srinivas | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Supplement – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Strynadka, Natalie C | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Preventing Opioid Deaths due to COVID Related Increase in Smoking Illicit Substances (Preventing OD CRISIS)

COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein

COVID-19 Variant Supplement – Assessing the impact of the COVID‑19 pandemic on social and health outcomes among young people: A mixed-method comparative analysis in Canada and France

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Investigating Neuropsychological Consequences of COVID‑19 on Adults, and Examination of Associated Risk and Resilience Factors

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Investigating access to and outcomes from supervised drug consumption services in British Columbia before and during the COVID‑19 pandemic

COVID-19 Variant Supplement – Canadian Treatments for COVID-19: SOLIDARITY

COVID-19 Variant Supplement – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases